psychiatry

A recent study published by Imène Kacem et al. in Frontiers in Psychiatry found an association between electric power plant workers’ exposure to extremely low frequency electromagnetic fields (ELF-EMF) and negative impacts to mental health and sleep quality. ELF-EMF, commonly referred to simply as EMF, is an exposure people experience from close proximity to electrical grid infrastructure, includ…
BackgroundPost-stroke depression (PSD) is the most common neuropsychiatric complication following stroke. Puerarin (PU), the principal bioactive compound extracted from the medicinal and edible plant Pueraria lobata, has shown beneficial therapeutic effects in both depression and stroke. However, the therapeutic effect of PU on PSD and its underlying mechanisms remain unclear. This study investig…

Bipolar Depression Remains a Major Therapeutic Challenge When people think about bipolar disorder, mania often receives much of the attention. Yet for many patients, depression represents the dominant burden of the illness. People with bipolar disorder spend substantially more time... The post SAINT® TMS for Bipolar Depression: Can Personalized, Accelerated Neuromodulation Change the Brain and De…

For adults with attention-deficit/hyperactivity disorder (ADHD) who also have children with ADHD, pairing a stimulant medication with a parenting intervention can lead to significant reductions in their child’s ADHD severity. The findings were published in the Journal of Child Psychology and Psychiatry .

Differentiating Bipolar Spectrum Disorders From Other Psychiatric Disorders With Shared Features Mohamed Soliman, MD, on why bipolar disorder often hides inside familiar symptoms, the four questions that reveal the underlying pattern, and how to choose the right screening tool for your setting. The post Differentiating Bipolar Spectrum Disorders From Other Psychiatric Disorders With Shared Featur…
IntroductionOlder adults with depressive episodes are frequently treated in the context of psychiatric multimorbidity, somatic co-treatment, and polypharmacy, increasing their vulnerability to drug-drug interactions (DDIs) and cumulative medication-related risk. This study characterized DDI burden and exploratory prescribing risk profiles among psychogeriatric outpatients, focusing on patients wi…

A small U.S. clinical trial suggests that combining psilocybin-assisted therapy with structured counselling may offer new hope for veterans living with severe post-traumatic stress disorder. The research, published in Communications Medicine, found impressive symptom improvements while also showing the treatment could be delivered safely in a carefully monitored medical setting. PTSD affects many…
FRIDAY, Aug. 21, 2026 — Oregon’s landmark psilocybin program is showing that the “magic mushroom” chemical can help people manage their mood disorders, a new study says.People participating in state-regulated psilocybin services reported relief...
Nature Medicine, Published online: 21 August 2026; doi:10.1038/s41591-026-04571-8 The largest multiomic atlas of the adult human hippocampus identifies disrupted neurogenesis, gene regulation and neural circuits in major depressive disorder, revealing molecular pathways and potential therapeutic targets related to stress, cellular aging and neuroplasticity.
Nature Medicine, Published online: 21 August 2026; doi:10.1038/s41591-026-04597-y A feasibility trial delivering psilocybin-assisted therapy for treatment-resistant depression within the UK health service reports encouraging adherence and safety — it opens future questions about who is reached, where treatment happens and what standards will be needed to sustain it.
Schizophrenia can affect how a person perceives reality, thinks, and communicates, sometimes causing hallucinations, delusions,...

For those living in the shadow of mental health conditions such as PTSD, anxiety, and...
Researchers are exploring whether magic mushrooms could offer a new treatment for anorexia
Diagnostics World | Researchers at The University of Texas MD Anderson Cancer Center are investigating whether immune-system biomarkers could help identify cancer patients most likely to benefit from rapid-acting psychedelic treatments for depression. Researchers examined whether these rapid-acting antidepressants share biological pathways that could serve as biomarkers for future treatment strat…

research.ioSign up to keep scrolling
Create your feed subscriptions, save articles, keep scrolling.








